BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25.08.2008

FDA Regulations; Technical Amendment

The Food and Drug Administration (FDA) is amending a regulatory hearing process regulation to correct an inaccurate citation, and regulations pertaining to biological products to correct two typographical errors. FDA is also amending certain medical device regulations to include references to and mailing address information for the Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), and Center for Devices and Radiological Health (CDRH). This action is being taken to ensure the accuracy of FDA's regulations.

Source: Federal Register — Food and Drug AdministrationOpen original release →